All Stories

  1. Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers

    Article • Proceedings of the National Academy of Sciences, August 2021, Proceedings of the National Academy of Sciences

    SADASHIVA KARNIK

  2. Angiotensin Type 1 Receptor Blockers in Heart Failure

    Article • Current Drug Targets, January 2020, Bentham Science Publishers

    SADASHIVA KARNIK

  3. Angiotensin II increases angiogenesis by NF-κB–mediated transcriptional activation of angiogenic factor AGGF1

    Article • The FASEB Journal, September 2018, Federation of American Societies For Experimental Biology (FASEB)

    SADASHIVA KARNIK

  4. The non-biphenyl-tetrazole angiotensin AT1 receptor antagonist eprosartan is a unique and robust inverse agonist of the active state of the AT1 receptor

    Article • British Journal of Pharmacology, May 2018, Wiley

    Takanobu Takezako, SADASHIVA KARNIK

  5. Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22

    Article • British Journal of Pharmacology, March 2017, Wiley

    SADASHIVA KARNIK

  6. International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli

    Article • Pharmacological Reviews, August 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    SADASHIVA KARNIK